Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Surg Obes Relat Dis. 2013 Jul 12;9(6):10.1016/j.soard.2013.07.003. doi: 10.1016/j.soard.2013.07.003

Table 6.

Relationship between sexual functioning, quality of life scores, and sex hormone levels.

Male Erectile Dysfunction
(n=47)
Female Sexual Dysfunction
(n=163)
Female Hypoactive Sexual
Dysfunction Disorder
(n=163)

n %
Change
95% CI P-
value
n %
Change
95% CI P-
value
n %
Change
95% CI P-
value
SF-36
  PCS 41 −4.27 (−8.00, −0.40) 0.03 131 −2.34 (−4.23, −0.41) 0.02 138 −1.64 (− 3.31, 0.06) 0.06
  MCS 41 −0.44 (− 5.83, 5.27) 0.88 131 −3.07 (− 4.21, −1.91) <0.001 138 −1.89 (− 3.11, −0.65) 0.003
IWQOL
  Total 41 −3.23 (− 6.19, −0.17) 0.04 133 −2.67 (− 3.60, −1.73) <0.001 140 −1.59 (−2.46, −0.72) <0.001
  Work 38 −1.21 (− 3.30, 0.91) 0.26 126 −1.15 (− 1.75, −0.55) <0.001 133 −0.74 (− 1.31, −0.16) 0.01
  Phys Func 41 −2.33 (− 4.44, −0.19) 0.03 133 −1.55 (− 2.48, −0.62) 0.001 140 −1.11 (− 1.91, −0.30) 0.01
  Distress 41 −1.38 (− 2.98, 0.24) 0.09 133 −0.83 (− 1.61, −0.04) 0.04 140 −0.14 (− 0.83, 0.56) 0.70
  Sex Life 41 −2.19 (− 3.53, −0.83) 0.002 133 −2.64 (− 3.25, −2.02) <0.001 140 −1.82 (− 2.38, −1.26) <0.001
  SE 41 −0.95 (− 2.77, 0.89) 0.31 133 −1.73 (− 2.43, −1.03) <0.001 140 −0.89 (− 1.54, −0.24) 0.01
BIQLI
  Total 42 −1.84 (− 34.31, 46.68) 0.93 136 −23.43 (− 34.42, −10.60) <0.001 143 −15.00 (− 25.60, −2.88) 0.02
BSQ Total 42 1.06 (− 0.65, 2.81) 0.23 136 1.20 (0.61, 1.80) <0.001 143 0.50 (− 0.04, 1.04) 0.07
DAS
  Total 42 0.69 (− 1.63, 3.07) 0.56 135 −1.56 (− 2.17, −0.94) <0.001 142 −0.76 (− 1.38, −0.14) 0.02
Consensus 42 3.90 (− 2.18, 10.36) 0.21 135 −3.53 (− 5.22, −1.81) <0.001 142 −0.73 (− 2.60, 1.17) 0.45
Satisfaction 42 1.90 (− 4.67, 8.91) 0.58 135 −4.19 (− 5.73, −2.61) <0.001 142 −2.23 (− 3.81, −0.61) 0.01
  Cohesion 42 0.49 (− 9.74, 11.89) 0.93 135 −3.89 (− 7.63, 0.01) 0.051 142 −3.29 (− 6.43, −0.06) 0.046
  Affection Exp 42 −5.75 (− 21.42, 13.03) 0.52 133 −13.49 (− 17.62, −9.15) <0.001 139 −10.99 (− 14.84, −6.96) <0.001
BDI Total 37 5.34 (− 0.85, 11.91) 0.09 125 4.19 (2.66, 5.74) <0.001 130 3.06 (1.54, 4.60) <0.001
Sex Hormones
Estradiol* - - - - - 127 −0.10 (− 0.34, 0.14) 0.43 133 −0.21 (− 0.47, 0.05) 0.12
  Total Test 39 0.03 (− 0.47, 0.54) 0.90 127 0.25 (− 0.34, 0.84) 0.41 133 0.25 (− 0.27, 0.78) 0.34
  Free Test* 39 −13.34 (− 29.09, 5.92) 0.16 - - - - - - - - - -
  FSH - - - - - 126 −0.04 (− 0.92, 0.84) 0.93 132 −0.22 (− 1.06, 0.64) 0.62
  LH 39 4.03 (− 2.59, 11.09) 0.24 125 0.36 (− 1.17, 1.91) 0.65 131 −0.24 (− 1.89, 1.44) 0.78
  SHBG§ 39 −2.00 (− 7.86, 4.24) 0.52 127 −0.71 (−1.35, −0.07) 0.03 133 −0.32 (− 0.86, 0.23) 0.25
  DHEA-S - - - - - 127 −0.04 (− 0.20) 0.74 133 −0.17 (− 0.09) 0.20

n is the total number of participants used in each analysis

Percent change is the average percent change in the risk of sexual functioning problem per unit increase in the row variable, adjusting for type of patient (bariatric surgery patient or lifestyle modification patient) CI denotes the confidence interval

SF-36 = Short Form Health Survey; PCS = Physical Component Summary; MCS = Mental Component Summary; IWQOL = Impact of Weight on Quality of Life-Lite; Phys Func = IWQOL Physical Function subscale score; SE = IWQOL Self-esteem subscale score; BIQLI = Body Image Quality of Life; BSQ = Body Shape Questionnaire; DAS = Dyadic Adjustment Scale; Affection Exp = DAS Affectional Expression subscale score; BDI = Beck Depression Inventory-II; Total Test = Total Testosterone; Free Test = Free Testosterone; FSH = Follicle Stimulating Hormone; LH = Luteinizing Hormone; SHBG = Sex Hormone Binding Globulin; DHEA-S = Dehydroepiandrosterone Sulfate; N/A = Not applicable.

*

pg/mL;

ng/dL;

miu/mL;

§

nmol/L;

ug/dL